Related Experiment Video

Updated: Mar 29, 2026

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.7K

New insights into the mechanisms of multidrug resistance in cancers

N Montazami1, M Aghapour2, S Farajnia1

  • 1Tabriz University of Medical Sciences Immunology Research Center Tabriz Iran.

Cellular and Molecular Biology (Noisy-Le-Grand, France)
|November 28, 2015
PubMed

Insights

Drug resistance, particularly multidrug resistance (MDR), hinders cancer chemotherapy. This review explores MDR mechanisms, MDR1 gene expression, and novel inhibition strategies to overcome treatment failure and improve patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Drug resistance is a significant challenge in cancer treatment, leading to tumor recurrence and mortality.
  • Chemotherapy is a primary cancer treatment, but its effectiveness is often compromised by drug resistance.
  • Multidrug resistance (MDR) is a key mechanism where cancer cells evade chemotherapy drugs.

Purpose of the Study:

  • To review recent mechanisms contributing to chemotherapeutic resistance.
  • To examine the role of MDR1 gene expression in tumor resistance.
  • To discuss novel inhibition-based strategies for overcoming MDR.

Main Methods:

  • Literature review of recent research on cancer drug resistance.
  • Analysis of studies investigating MDR1 gene expression in tumors.
  • Exploration of emerging therapeutic approaches targeting MDR.

Main Results:

  • Chemotherapeutic resistance, including MDR, involves complex molecular mechanisms.
  • MDR1 gene overexpression is a significant factor in acquired multidrug resistance.
  • Novel inhibition strategies show promise in reversing or preventing MDR.

Conclusions:

  • Understanding MDR mechanisms and MDR1 gene expression is crucial for effective cancer therapy.
  • Targeting MDR offers a promising avenue to improve chemotherapy outcomes.
  • Further research into novel inhibition-based approaches is warranted to combat cancer drug resistance.

More Related Videos

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

14.5K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.3K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K